Chemotherapeutics Nos



Indications and Reactions:

Role Indications Reactions
Secondary
Chronic Myeloid Leukaemia 12.1%
Breast Cancer 11.2%
Product Used For Unknown Indication 11.2%
Foetal Exposure During Pregnancy 6.3%
Metastases To Bone 5.8%
Acute Leukaemia 5.4%
Bone Neoplasm Malignant 5.4%
Hypertension 4.5%
Breast Cancer Metastatic 4.0%
Hodgkin's Disease 4.0%
Acute Lymphocytic Leukaemia Recurrent 3.6%
Ovarian Cancer 3.6%
Acute Lymphocytic Leukaemia 3.1%
Anaemia 3.1%
Diabetes Mellitus 3.1%
Multiple Myeloma 3.1%
Non-hodgkin's Lymphoma 3.1%
Prostate Cancer 2.7%
Iron Overload 2.2%
Neuroendocrine Tumour 2.2%
Weight Decreased 11.1%
Tooth Extraction 10.0%
Weight Increased 6.7%
Nausea 5.6%
Prostatic Specific Antigen Increased 5.6%
Rash 5.6%
White Blood Cell Count Decreased 5.6%
Death 4.4%
Pyrexia 4.4%
Respiratory Tract Inflammation 4.4%
Stem Cell Transplant 4.4%
Thrombosis 4.4%
Vomiting 4.4%
Fatigue 3.3%
Headache 3.3%
Leukopenia 3.3%
Neutropenia 3.3%
Nonspecific Reaction 3.3%
Sepsis 3.3%
Septic Shock 3.3%
Concomitant
Multiple Myeloma 26.6%
Metastases To Bone 11.4%
Pain 10.1%
Breast Cancer 9.8%
Hypertension 5.4%
Osteoporosis 5.2%
Neoplasm Malignant 4.4%
Prostate Cancer 3.9%
Product Used For Unknown Indication 3.1%
Depression 2.9%
Anxiety 2.5%
Breast Cancer Metastatic 2.2%
Acute Lymphocytic Leukaemia 2.0%
Anaemia 1.9%
Eczema 1.8%
Myelodysplastic Syndrome 1.7%
Prostate Cancer Metastatic 1.3%
Schizophrenia 1.3%
Drug Use For Unknown Indication 1.3%
Nausea 1.2%
Weight Decreased 20.1%
Tooth Extraction 13.3%
Vomiting 7.5%
White Blood Cell Count Decreased 7.0%
Osteonecrosis Of Jaw 6.4%
Vision Blurred 6.2%
Wound Dehiscence 4.7%
Toothache 4.5%
Osteonecrosis 3.6%
Urinary Tract Infection 3.6%
Wound Drainage 3.1%
Swelling 2.6%
Walking Aid User 2.5%
Wheezing 2.5%
Pyrexia 2.3%
Weight Increased 2.3%
Vertebroplasty 2.2%
White Blood Cell Count Increased 2.0%
Death 1.9%
Tooth Fracture 1.8%
Interacting
Hiv Infection 57.1%
Hepatic Neoplasm Malignant 28.6%
Breast Cancer 14.3%
Blister 50.0%
Musculoskeletal Pain 50.0%